News

Posted On: 01/19/2006

Solvay Pharma Names Shlevin Global SVP

PharmaManufacturing.com

Solvay Pharmaceuticals on Jan. 19 announced the promotion of Harold H. Shlevin, Ph.D. to Global Senior Vice President of the newly formed global Regulatory, External Affairs, Safety and Quality Strategies (RESQS) organization, effective Jan. 1.

In his new post, Shlevin reports to Dr. Werner Cautreels, global CEO of Solvay Pharmaceuticals. Formerly (since 2000), he had served as President and CEO of Solvay Pharmaceuticals, Inc., in the United States and is succeeded in that position by Laurence Downey, MD.

Shlevin will continue to serve as a member of the board of directors for the U.S. pharmaceuticals organization and will assume additional responsibilities as a member of both the executive directors committee and the board of directors for the global Solvay Pharmaceuticals organization.

"The RESQS organization will align several important areas of the global Solvay Pharmaceuticals organization including global quality, global drug safety and surveillance, global regulatory affairs and external affairs," said Cautreels. "Dr. Shlevin's experience and expertise is ideally suited to help structure the development and establishment of this newly-created organization."

An eight- year veteran of the company, Shlevin achieved record growth during his term as president and CEO of Marietta, Ga.-based Solvay Pharmaceuticals, Inc. Prior to this, he was with CIBA Vision Ophthalmic and Ciba-Geigy Pharmaceuticals. He currently serves on the board of directors of the Pharmaceutical Research and Manufacturers Association of America, National Pharmaceutical Council, the American Foundation for Suicide Prevention, the board of visitors of Morehouse School of Medicine and the board of Cardiome Pharma.

For more information on Solvay Pharmaceuticals, visit www.solvaypharmaceuticals-us.com.